Colgate's Pricing Power Meets Its First Real Test Since Cost Warnings Began

Colgate-Palmolive (CL) reports second-quarter 2026 earnings on Thursday, July 31, before the market opens, with Wall Street focused on whether the consumer staples giant's pricing power can offset an estimated $300 million in incremental raw material and logistics cost pressure. The company has beaten consensus EPS estimates in four consecutive quarters, but management's recent downward revision to full-year gross margin guidance has raised questions about profitability sustainability. For a stock that has climbed nearly 20% year-to-date, this report will test whether that rally reflects durable fundamentals or optimism that may prove premature.

Part 1: Earnings Preview

Colgate-Palmolive manufactures and markets oral care, personal care, home care, and pet nutrition products, selling in over 200 countries with roughly 70% of revenue generated internationally. The company's portfolio includes iconic brands like Colgate toothpaste, Palmolive soap, and Hill's Pet Nutrition, making it a bellwether for global consumer demand and emerging market trends.

Analysts expect Colgate-Palmolive to report second-quarter EPS of $0.95, representing a 3.26% increase from the $0.92 posted in the second quarter of 2025. Revenue estimates range from $5.31 billion to $5.36 billion, implying roughly 4% to 5% year-over-year growth from the prior-year period's $5.11 billion. The company most recently reported first-quarter 2026 EPS of $0.97, which exceeded the $0.95 consensus estimate.

Three key themes define this earnings story:

Gross Margin Pressure vs. Pricing Power — Management has warned that full-year gross margins will decline year-over-year, with approximately two-thirds of the $300 million cost headwind stemming from elevated raw materials (resins, petrochemicals, fats and oils) and the remainder from logistics inflation tied to oil prices near $110 per barrel. Investors will scrutinize whether revenue management initiatives and pricing actions can offset these input cost pressures without sacrificing volume.

Emerging Market Momentum — Latin America and Asia Pacific showed particular strength in Q1, with organic sales growth of 2.9% company-wide. International markets account for the majority of Colgate-Palmolive's business, and sustained momentum in these geographies is critical to offsetting tariff-related headwinds in North America. Volume trends and market share data from these regions will signal whether the company can maintain its growth trajectory.

Hill's Pet Nutrition Performance — The pet food segment delivered 4.8% organic sales growth (excluding private label) in Q1, representing a bright spot in the portfolio. The strategic exit from private-label pet food is expected to create a 20 to 30 basis point headwind at the company level during Q2, though this drag should fade in the second half. Investors will watch whether the core Hill's business can sustain its growth rate and offset the near-term dilution from the portfolio rationalization.

Analyst commentary ahead of the release reflects cautious optimism. The consensus view acknowledges Colgate-Palmolive's consistent execution and track record of earnings beats, but notes that the margin outlook creates a higher bar for upside surprises. Several analysts have reconfirmed estimates over the last 30 days, suggesting expectations are well-anchored. The focus will be on management's updated guidance for the second half of the year, particularly whether commodity cost pressures are stabilizing or accelerating.

Part 2: Historical Earnings Performance

Colgate-Palmolive has demonstrated consistent execution over the past four quarters, beating Wall Street EPS estimates in every report. The company posted earnings surprises of 3.37%, 2.25%, 4.40%, and 2.11% in the second, third, and fourth quarters of 2025 and the first quarter of 2026, respectively. The magnitude of beats has ranged from $0.02 to $0.04 per share, with the largest upside surprise occurring in Q4 2025 when the company reported $0.95 against a $0.91 estimate.

The pattern reveals improving earnings momentum on an absolute basis, with reported EPS climbing from $0.92 in Q2 2025 to $0.97 in Q1 2026. This progression reflects the company's ability to drive earnings growth despite a challenging operating environment marked by commodity inflation and currency headwinds. The consistency of beats suggests management has maintained conservative guidance or that operational execution has consistently exceeded internal expectations.

For the upcoming Q2 2026 report, the year-over-year comparison shows the consensus estimate of $0.95 represents a 3.26% increase from the $0.92 reported in the same quarter last year. This modest growth rate, combined with management's warnings about margin pressure, suggests the bar for another beat may be higher than in recent quarters. However, the established pattern of outperformance gives investors reason to anticipate potential upside, particularly if pricing actions and emerging market strength offset cost headwinds more effectively than expected.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Colgate-Palmolive reports before the market opens, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.

Historical price behavior shows significant volatility around earnings releases, with Day 0 absolute moves averaging 2.79% and ranging as high as 5.92%. The most dramatic reaction occurred following the Q4 2025 report in January 2026, when the stock surged 5.92% on earnings day and added another 1.77% the following session. Conversely, the stock declined 4.61% following the Q1 2025 report and 4.14% after Q3 2024 results, demonstrating that disappointments can trigger sharp selloffs.

The pattern reveals that positive earnings surprises tend to generate sustained momentum, as evidenced by the Q4 2025 and Q3 2024 reports where Day 0 gains were followed by additional upside on Day +1. In contrast, negative initial reactions have typically stabilized quickly, with Day +1 moves often reversing or moderating the prior session's decline. The average Day +1 move of 1.50% suggests follow-through activity is common, though less volatile than the initial reaction.

Investors should anticipate a move in the 2% to 3% range based on historical patterns, with the potential for larger swings if results materially exceed or miss expectations on margins or guidance. The stock's recent 20% year-to-date gain may amplify downside risk if the report disappoints, as elevated valuations can exacerbate profit-taking pressure.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 2.43% for this earnings release, slightly below the 2.79% average absolute Day 0 move observed over the past eight quarters. This suggests options traders are anticipating a relatively contained reaction compared to historical volatility, though the expected move still implies a potential swing of approximately $2.23 in either direction from the current price of $91.60.

Part 3: What Analysts Are Saying

Analyst sentiment on Colgate-Palmolive reflects a moderately bullish consensus, with an average recommendation of 3.95 on the five-point scale. The analyst community includes 10 Strong Buy ratings, 3 Moderate Buy ratings, 8 Hold ratings, and 1 Strong Sell rating among 22 total recommendations. This distribution skews positive, with approximately 59% of analysts rating the stock a buy (Strong Buy or Moderate Buy), while roughly 36% maintain a neutral stance.

The mean price target of $96.76 implies approximately 5.6% upside from the current price of $91.60, suggesting analysts see modest appreciation potential over the next 12 months. Price target estimates span a wide range, with the high estimate of $110.00 representing 20.1% upside and the low estimate of $75.00 implying 18.1% downside. This dispersion reflects divergent views on how effectively Colgate-Palmolive can navigate margin pressure and sustain growth momentum.

Analyst sentiment has remained unchanged over the past month, with no shifts in the overall recommendation profile or average rating. This stability suggests the analyst community has already incorporated management's margin guidance revision and cost headwind warnings into their models, and expectations are well-calibrated heading into the Q2 report. The lack of recent estimate revisions indicates analysts are waiting for the earnings release to provide updated data points before adjusting their outlooks.

Part 4: Technical Picture

Colgate-Palmolive's technical setup heading into earnings shows a Buy signal at 80%, strengthening from 64% last week but moderating from 88% last month. This recent improvement in the near-term signal suggests positive momentum has returned after a brief consolidation period, though the stock remains below several short-term resistance levels.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal indicates near-term momentum is positive but not overwhelming, suggesting the stock is in a transitional phase
• Medium-term (100% Buy): Strong buy signal across the intermediate timeframe reflects solid upward momentum over the past several weeks
• Long-term (100% Buy): Strong buy signal confirms the broader uptrend remains intact, supported by the stock's 20% year-to-date gain

Trend Characteristics: The Average strength and Weakest direction reading suggests the uptrend is intact but losing some momentum, indicating potential consolidation or a pause in the rally as the stock approaches resistance.

The stock is currently trading at $91.60, positioned below the 5-day ($92.11), 10-day ($91.77), and 20-day ($92.36) moving averages, indicating short-term resistance overhead. However, the stock remains above the 50-day ($90.86), 100-day ($88.50), and 200-day ($85.97) moving averages, confirming the longer-term uptrend is still supported.

The technical picture presents a mixed setup heading into earnings, with near-term resistance at the $92 to $92.50 zone (20-day moving average) potentially capping upside if results merely meet expectations. The stock's position above all major long-term moving averages provides a supportive foundation, but the recent pullback from short-term highs suggests some profit-taking ahead of the report. A strong earnings beat with improved margin guidance could propel the stock through overhead resistance toward the $94 to $95 range, while a disappointment could trigger a test of the 50-day moving average near $91. The overall setup is cautiously constructive, with the long-term trend intact but near-term momentum requiring confirmation from the earnings results.